A recent study indicates that patients who come off new GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who stop conventional lifestyle programs.
Findings released in a prominent health publication shows that while overweight people frequently drop about a fifth of their body weight while on the medication, the weight returns at an average rate of 0.8 kg per month upon discontinuation.
"Users using such treatments should be aware of the potential of rapid weight regain when the therapy is stopped," cautioned lead investigator Dr. Susan Jebb.
This pace of regain implies a reversion to original weight within about one and a half years.
Weighing Approaches
The analysis, which examined dozens of trials involving over 9,000 of patients, compared the effects of GLP-1 agonists with other pills.
Researchers emphasize that people who shed pounds through dieting usually experience a slower creep back—perhaps 100 grams monthly—after stopping.
Understanding the Rapid Rebound
Doctors propose the way of the jabs is key to understanding the accelerated rebound.
GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Sustained high doses of the hormone concentrations several times higher than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this GLP-1 'fix' leads to hunger is unsuppressed, making overeating a significant risk."
A Chronic Issue?
The NHS recommend the injections for individuals with weight-linked medical conditions, alongside recommended lifestyle changes.
Many experts say that, due to the likelihood of relapse, the treatment is often ongoing.
This opinion is supported by pharmaceutical companies, who note that the results "emphasize the chronic character of obesity," akin to managing conditions like hypertension.
User Accounts
Users who have stopped the jabs report a powerful resurgence of appetite.
"It was like a switch flipping and you're instantly ravenous," recalled one woman.
This difficulty is worsened if individuals have not adopted permanent lifestyle or habit modifications during treatment.
Growing Interest
Recent estimates suggest that millions of people in the UK have tried these injections in the past year, with interest continuing to grow.
- Adoption is higher among females compared to males.
- The middle-aged age group shows the highest level of interest.
- A large proportion access the drugs through private healthcare rather than the NHS.
In conclusion, researchers stress that while GLP-1 drugs are powerful tools for shedding pounds, they are not a magic solution and lasting health benefits relies on integrated lifestyle changes.
